3647 results for «686»
3647 results
Imaging-guided intravascular lithotripsy for calcified lesions - LIVE case
27 Feb 2026 – From Euro4C Annual Meeting 2026
This live educational case from St. Francis Hospital and Heart Center demonstrates imaging-guided intravascular lithotripsy for calcified lesions. It covers lesion selection criteria, preparation and delivery of lithotripsy catheters, and reviews recent clinical evidence to guide best practices.
LIVE Educational Case from St. Francis Hospital & Heart...
DK Crush like you’ve never seen it before
- Multi-modality simulation to unveil the hidden parts & small obstacles that can result in complications
- Angioscopy directly inside the coronary artery to provide a better understanding of 3D stent configuration
Commented by Goran Stankovic and William Wijns
Part 1 of a 3-part series.
Next episode: How to correct incomplete crush and...
How to correct incomplete crush and how to prevent lack of carina coverage
- Differentiating between complete and incomplete crush
- The importance of sequential crush and bigger balloons, adequately sized according to proximal vessel diameter
Commented by Goran Stankovic and William Wijns
Part 2 of a 3-part series:
Previous episode: DK Crush like you’ve never seen it before
Coming up next: Main vessel stenting in DK-Crush, lessons...
Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy
- Optimisation of side branch stenting
- How to optimally deploy the second stent
Commented by Goran Stankovic and William Wijns
Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage
A randomised trial comparing imaging-guided PCI with Orsiro vs Xience
18 May 2021
Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be associated with lower target lesion failure (TLF) when compared to durable polymer everolimus-eluting stents (DP-EES). However, the possible underlying mechanisms remain unclear. Therefore, the all-comers CASTLE study was designed to assess the...
Authors :
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation
05 Sep 2023
Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.
Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author
BIOFLOW DAPT - Biodegradable-polymer or durable-polymer stents in patients at high bleeding risk: A randomized, open-label clinical trial
26 Aug 2023
Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.
BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...

Author